HER2-positive Advanced Breast Cancer Clinical Trials

12 clinical trials for HER2-positive Advanced Breast Cancer across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer — RECRUITING · PHASE2
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer — RECRUITING · PHASE3
• Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases — RECRUITING · PHASE2
• T-DM1 Combined With CDK4/6 Inhibitor Ribociclib — RECRUITING · PHASE2
• Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC — RECRUITING
• PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR ERIBULIN MESYLATE) IN HER2-POSITIVE ADVANCED BREAST CANCER (The JAZMINE Study) — TERMINATED · PHASE2
• EPIK-B2: A two part, Phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with trastuzumab and pertuzumab as maintenance therapy in patients with HER2-positive advanced breast cancer with a PIK3CA mutation — OTHER · PHASE3
• DP303c in Patients With HER2-positive Advanced Breast Cancer — NOT_YET_RECRUITING · PHASE3
• Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer — COMPLETED · PHASE2
• RWS of Inetetamab HER2 Positive Advanced Breast Cancer — OTHER
• The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer — OTHER · PHASE3

Refine this search